The global Antihyperlipidemic Drugs Market is estimated to reach a value of US$ 12.6 Bn in 2022, with a projected CAGR of 7.5% during the forecast period of 2023-2030.
Antihyperlipidemic drugs are used to lower high levels of lipids (cholesterol and triglycerides) in the blood, reducing the risk of cardiovascular diseases. The market for these drugs is driven by the increasing ... Read more
